Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.23 +0.13 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Atara Biotherapeutics (ATRA) FCF Margin (2021 - 2026)

Updated

Atara Biotherapeutics (ATRA) posted FCF Margin of -529.84% for Q2 2026, down 488.20 percentage points from -41.64% a year earlier but up 65.70 percentage points from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) FCF Margin (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Atara Biotherapeutics was -353.49%, down 319.56 percentage points year-over-year; for FY2025, it was -42.18%, up 11.31 percentage points from FY2024.

  • Annual FCF Margin shows a four-year change of +1094.02 percentage points (FY2021 to FY2025).
  • In prior years, Atara Biotherapeutics' FCF Margin was -53.48% in FY2024 (+2211.77 pp), -2265.25% in FY2023 (-1833.45 pp), -431.80% in FY2022 (+704.40 pp) and -1136.19% in FY2021.
  • Quarterly FCF Margin has run from a low of -22950.40% in Q4 2022 to a high of -9.93% in Q3 2024 over five years.
  • On a year-over-year basis, FCF Margin has declined in each of the last five quarters, with an average year-over-year change of +247.65 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2023, with a gain of 21763.90 percentage points; the weakest was Q4 2022, with a drop of 22463.72 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was -595.54% (Q1 2026), -357.18% (Q4 2025) and -283.43% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.03%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 41.97%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.51%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 52.85%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.25%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 57.81%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 28.96%
10 Atara Biotherapeutics 124.14 Mn 114.24 Mn 959,000.00 -71.81%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -71.81%
Jun 30, 2026 -529.84%
Mar 31, 2026 -595.54%
Dec 31, 2025 -357.18%
Sep 30, 2025 -283.43%
Jun 30, 2025 -41.64%
Mar 31, 2025 -28.67%
Dec 31, 2024 -74.99%
Sep 30, 2024 -9.93%
Jun 30, 2024 -37.27%
Mar 31, 2024 -108.71%
Dec 31, 2023 -1,186.50%
Sep 30, 2023 -2,414.73%
Jun 30, 2023 -5,568.97%
Mar 31, 2023 -3,167.05%
Dec 31, 2022 -22,950.40%
Sep 30, 2022 -1,461.96%
Jun 30, 2022 -126.76%
Mar 31, 2022 -1,191.33%
Dec 31, 2021 -486.69%
API Access

Atara Biotherapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ATRA&period=max&api_key=YOUR_API_KEY